|
1
|
World Health Organization (WHO), . Global
Cancer Observatory. WHO; Geneva: 2020, https://gco.iarc.frNovember 10–2020
|
|
2
|
Høydahl Ø, Edna TH, Xanthoulis A, Lydersen
S and Endreseth BH: Long-term trends in colorectal cancer:
Incidence, localization, and presentation. BMC Cancer. 20:10772020.
View Article : Google Scholar
|
|
3
|
Mattiuzzi C, Sanchis-Gomar F and Lippi G:
Concise update on colorectal cancer epidemiology. Ann Transl Med.
7:6092019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
American Cancer Society, . Survival Rates
for Colorectal Cancer. American Cancer Society; Atlanta, GA: 2020,
https://www.cancer.org/camcer/colon-rectal-cancer/detection-diagnosis-staging/survival-rates.htmlNovember
10–2020
|
|
5
|
Hamilton SR, Bosman FT and Boffetta P:
Carcinoma of the colon and rectum. WHO Classification of Tumours of
the Digestive System. Bosman FT, Carneiro F, Hruban RH and Theise
ND: IARC Press; Lyon: pp. 134–46. 2000
|
|
6
|
Cammarota R, Bertolini V, Pennesi G, Bucci
EO, Gottardi O, Garlanda C, Laghi L, Barberis MC, Sessa F, Noonan
DM and Albini A: The tumor microenvironment of colorectal cancer:
Stromal TLR-4 expression as a potential prognostic marker. J Transl
Med. 8:1122010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park JH, McMillan DC, Powell AG, Richards
CH, Horgan PG, Edwards J and Roxburgh CS: Evaluation of a tumor
microenvironment-based prognostic score in primary operable
colorectal cancer. Clin Cancer Res. 21:882–888. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Qiu L, Li Z, Wang XY and Yi H:
Understanding the multifaceted role of neutrophils in cancer and
autoimmune diseases. Front Immunol. 9:24562018. View Article : Google Scholar
|
|
9
|
Ullman TA and Itzkowitz SH: Intestinal
inflammation and cancer. Gastroenterology. 140:1807–1816. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rao HL, Chen JW, Li M, Xiao YB, Fu J, Zeng
YX, Cai MY and Xie D: Increased intratumoral neutrophil in
colorectal carcinomas correlates closely with malignant phenotype
and predicts patients' adverse prognosis. PLoS One. 7:e308062012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Väyrynen SA, Väyrynen JP, Klintrup K,
Mäkelä J, Karttunen TJ, Tuomisto A and Mäkinen MJ: Clinical impact
and network of determinants of tumour necrosis in colorectal
cancer. Br J Cancer. 114:1334–1342. 2016. View Article : Google Scholar
|
|
12
|
Szabó C: Mechanisms of cell necrosis. Crit
Care Med. 33 (Suppl 12):S530–S534. 2005. View Article : Google Scholar
|
|
13
|
Pollheimer MJ, Kornprat P, Lindtner RA,
Harbaum L, Schlemmer A, Rehak P and Langner C: Tumor necrosis is a
new promising prognostic factor in colorectal cancer. Hum Pathol.
41:1749–1757. 2010. View Article : Google Scholar
|
|
14
|
Klarskov L, Holck S, Bernstein I, Okkels
H, Rambech E, Baldetorp B and Nilbert M: Challenges in the
identification of MSH6-associated colorectal cancer: Rectal
location, less typical histology, and a subset with retained
mismatch repair function. Am J Surg Pathol. 35:1391–1399. 2011.
View Article : Google Scholar
|
|
15
|
Zhang X and Chen L: The recent progress of
the mechanism and regulation of tumor necrosis in colorectal
cancer. J Cancer Res Clin Oncol. 142:453–463. 2016. View Article : Google Scholar
|
|
16
|
Benson AB, Venook AP, Al-Hawary MM,
Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Engstrom PF, et al: NCCN guidelines insights: Colon cancer, version
2.2018. J Natl Compr Canc Netw. 16:359–369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hirahara T, Arigami T, Yanagita S,
Matsushita D, Uchikado Y, Kita Y, Mori S, Sasaki K, Omoto I,
Kurahara H, et al: Combined neutrophil-lymphocyte ratio and
platelet-lymphocyte ratio predicts chemotherapy response and
prognosis in patients with advanced gastric cancer. BMC Cancer.
19:6722019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jakubowska K, Koda M, Grudzińska M,
Kańczuga-Koda K and Famulski W: Monocyte-to-lymphocyte ratio as a
prognostic factor in peripheral whole blood samples of colorectal
cancer patients. World J Gastroenterol. 26:4639–4655. 2020.
View Article : Google Scholar
|
|
20
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA;
WHO Classification of Tumours Editorial Board, : The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng
P, Xu P, Zhu D, Ji M and Xu J: Tumor deposit is a poor prognostic
indicator in patients who underwent simultaneous resection for
synchronous colorectal liver metastases. Onco Targets Ther.
8:233–240. 2015.PubMed/NCBI
|
|
22
|
Mayadas TN, Cullere X and Lowell CA: The
multifaceted functions of neutrophils. Annu Rev Pathol. 9:181–218.
2014. View Article : Google Scholar
|
|
23
|
Harbaum L, Pollheimer MJ, Kornprat P,
Lindtner RA, Bokemeyer C and Langner C: Peritumoral eosinophils
predict recurrence in colorectal cancer. Mod Pathol. 28:403–413.
2015. View Article : Google Scholar
|
|
24
|
Jakubowska K, Koda M, Kisielewski W,
Kańczuga-Koda L and Famulski W: Prognostic significance of
inflammatory cell response in patients with colorectal cancer.
Oncol Lett. 18:783–791. 2019.
|
|
25
|
Gao JF, Arbman G, Wadhra TI, Zhang H and
Sun XF: Relationships of tumor inflammatory infiltration and
necrosis with microsatellite instability in colorectal cancers.
World J Gastroenterol. 11:2179–2183. 2005. View Article : Google Scholar
|
|
26
|
Ling YH, Chen JW, Wen SH, Huang CY, Li P,
Lu LH, Mei J, Li SH, Wei W, Cai MY and Guo RP: Tumor necrosis as a
poor prognostic predictor on postoperative survival of patients
with solitary small hepatocellular carcinoma. BMC Cancer.
20:6072020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Jiang C, Zhang D, Gao M, Peng F,
Huang D, Sun Z, Ni Y, Zhang J and Yin Z: Tumor necrosis targeted
radiotherapy of non-small cell lung cancer using radioiodinated
protohypericin in a mouse model. Oncotarget. 6:26400–26410. 2015.
View Article : Google Scholar
|
|
28
|
Whalen GF: Solid tumours and wounds:
Transformed cells misunderstood as injured tissue? Lancet.
336:1489–1492. 1990. View Article : Google Scholar
|
|
29
|
Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin
K, Huang Q, Shi X, Ni Z, Ding N, et al: Tumor-infiltrating immune
cells act as a marker for prognosis in colorectal cancer. Front
Immunol. 10:23682019. View Article : Google Scholar
|
|
30
|
Galdiero MR, Bianchi P, Grizzi F, Di Caro
G, Basso G, Ponzetta A, Bonavita E, Barbagallo M, Tartari S,
Polentarutti N, et al: Occurrence and significance of
tumor-associated neutrophils in patients with colorectal cancer.
Int J Cancer. 139:446–456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu
Z, Yin XY and Zheng L: Peritumoral neutrophils link inflammatory
response to disease progression by fostering angiogenesis in
hepatocellular carcinoma. J Hepatol. 54:948–955. 2011. View Article : Google Scholar
|
|
32
|
Berry RS, Xiong MJ, Greenbaum A, Mortaji
P, Nofchissey RA, Schultz F, Martinez C, Luo L, Morris KT and
Hanson JA: High levels of tumor-associated neutrophils are
associated with improved overall survival in patients with stage II
colorectal cancer. PLoS One. 12:e01887992017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wikberg ML, Ling A, Li X, Oberg A, Edin S
and Palmqvist R: Neutrophil infiltration is a favorable prognostic
factor in early stages of colon cancer. Hum Pathol. 68:193–202.
2017. View Article : Google Scholar
|
|
34
|
Swinson DE, Jones JL, Richardson D, Cox G,
Edwards JG and O'Byrne KJ: Tumour necrosis is an independent
prognostic marker in non-small cell lung cancer: Correlation with
biological variables. Lung Cancer. 37:235–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schneider NI and Langner C: Prognostic
stratification of colorectal cancer patients: Current perspectives.
Cancer Manag Res. 6:291–300. 2014.PubMed/NCBI
|
|
36
|
O'Neil M and Damjanov I: Histopathology of
colorectal cancer after neoadjuvant chemoradiation therapy. Open
Pathol J. 3:91–98. 2009. View Article : Google Scholar
|
|
37
|
Bredholt G, Mannelqvist M, Stefansson IM,
Birkeland E, Bø TH, Øyan AM, Trovik J, Kalland KH, Jonassen I,
Salvesen HB, et al: Tumor necrosis is an important hallmark of
aggressive endometrial cancer and associates with hypoxia,
angiogenesis and inflammation responses. Oncotarget. 6:39676–39691.
2015. View Article : Google Scholar
|
|
38
|
Richards CH, Roxburgh CS, Anderson JH,
McKee RF, Foulis AK, Horgan PG and McMillan DC: Prognostic value of
tumour necrosis and host inflammatory responses in colorectal
cancer. Br J Surg. 99:287–294. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Komori K, Kanemitsu Y, Kimura K, Hattori
N, Sano T, Ito S, Abe T, Senda Y, Misawa K, Ito Y, et al: Tumor
necrosis in patients with TNM stage IV colorectal cancer without
residual disease (R0 Status) is associated with a poor prognosis.
Anticancer Res. 33:1099–1105. 2013.PubMed/NCBI
|
|
40
|
Jakubowska K, Kisielewski W, Kańczuga-Koda
L, Koda M and Famulski W: Diagnostic value of inflammatory cell
infiltrates, tumor stroma percentage and disease-free survival in
patients with colorectal cancer. Oncol Lett. 14:3869–3877. 2017.
View Article : Google Scholar
|
